Please enable JS

Biosimilar Confidence: Patient Perspectives on a New Medication Class – Seth Ginsberg

7/ 15

ARTICLE DETAILS

AUTHOR: 50SN Staff

DATE: Jul 15, 2016

TAGS:

SHARE ON: Twitter - Facebook - LinkedIn

Biosimilar Confidence: Patient Perspectives on a New Medication Class – Seth Ginsberg

Imagine you’ve been living with rheumatoid arthritis for more than ten years. Likely, it took several years to get a definitive diagnosis, with crucial time lost before landing at the doorstep of the expert (the rheumatologist). And then a bevy of sequential prescriptions ranging from steroids to methotrexate to biologics to find the medication, or combination of medications, that works well and minimizes flares. There’s a rollercoaster of emotions – fear, hope, reluctance, relief, which all vary person-to-person. But one thing is unanimous no matter who the patient is:  she or he must proactively be their own advocate in the care and management of their disease.

Click here to read more.


 

Font Resize